Report Overview:
A market that just keeps on growing.  Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics.  Learn all about it in this new report from Howe Sound Research.  A range of dynamic trends are pushing market growth and company valuations. 

Trends like ......
  • the genetic blizzard
  • emerging economies and global prosperity
  • pharmacogenomics
  • healthcare expansion in China
  • climate change
  • globalization
  • automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2018 United States Medicare Fee Payment Schedules to help sharpen your pricing.  Make facilities planning decisions.  Forecast demand for new testing regimes or technologies.  Make research investment decisions. 

Order an Enterprise Version specifically customized for your organizations needs for distribution throughout your company.

Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges.  Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.  Again, assistance in using the information is normally provided without additional charges.  Questions?  Email us at service at howesoundresearch.com.  We would be glad to let you know if we can be of help.

The report includes detailed breakouts for 15 Countries and 4 Regions.  A detailed breakout for any country in the world is available to purchasers of the report.

Make investment decisions and valuations with confidence using the latest data.